Detalhe da pesquisa
1.
Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry.
Am Heart J
; 263: 104-111, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37164146
2.
Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study.
Diabetes Spectr
; 34(2): 175-183, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34149258
3.
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 Diabetes.
Diabetes Ther
; 15(2): 427-445, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060149
4.
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).
Clin Drug Investig
; 44(4): 271-284, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507188
5.
Increased Healthcare Resource Use and Costs After Discontinuation of Liraglutide in Patients with Type 2 Diabetes from a Commercial- and Medicaid-Insured Claims Database.
Diabetes Ther
; 13(11-12): 1861-1874, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239850
6.
Glucose-lowering treatment patterns in patients with diabetic kidney disease.
Am J Manag Care
; 28(8): e301-e307, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35981131
7.
Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study.
Diabetes Ther
; 11(1): 213-228, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820328
8.
Injectable Antihyperglycemics: A Systematic Review and Critical Analysis of the Literature on Adherence, Persistence, and Health Outcomes.
Diabetes Ther
; 10(3): 865-890, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054132
9.
Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years.
Diabetes Ther
; 9(3): 1279-1293, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29744818
10.
Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective.
Clinicoecon Outcomes Res
; 10: 791-803, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30532570
11.
CLCN2 chloride channel mutations in familial hyperaldosteronism type II.
Nat Genet
; 50(3): 349-354, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29403011